West to Participate in Upcoming Investor Conferences

Rhea-AI Summary

West Pharmaceutical Services (NYSE: WST) has announced its participation in three upcoming investor conferences in November 2024. The company will present at the UBS Global Healthcare Conference in California on November 12 at 3:30 PM PST, the Jefferies Healthcare Conference in London on November 19 at 1:00 PM GMT, and the Stephens Annual Investment Conference in Nashville on November 21 at 10:00 AM CST.

Live audio webcasts will be available on the company's website investor section, with replays accessible for approximately 90 days following each event.

News Market Reaction – WST

+2.58%

+2.58% Session move

In the trading session that priced this news, WST gained 2.58%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

EXTON, Pa., Oct. 29, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the following conferences:

• UBS Global Healthcare Conference in Rancho Pablos Verdes, California, on November 12, 2024 at 3:30 PM PST
• Jefferies Healthcare Conference in London, UK on Tuesday, November 19, 2024 at 1:00 PM GMT
• Stephens Annual Investment Conference in Nashville, TN on Thursday, November 21, 2024 at 10:00 AM CST

A live audio webcast of these events will be available in the "Investors" section of the Company's website at www.westpharma.com. Replay of the webcasts will be available for approximately 90 days after the events. 

About West  
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With 10,000 team members across 50 sites worldwide, West helps support our customers by delivering approximately 43 billion components and devices each year.    

Headquartered in Exton, Pennsylvania, West in its fiscal year 2023 generated $2.95 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com.  

All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted. 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/west-to-participate-in-upcoming-investor-conferences-302289363.html

SOURCE West Pharmaceutical Services, Inc.

FAQ

What investor conferences will West Pharmaceutical Services (WST) attend in November 2024?

West Pharmaceutical Services will attend three conferences: UBS Global Healthcare Conference (Nov 12), Jefferies Healthcare Conference (Nov 19), and Stephens Annual Investment Conference (Nov 21).

How can investors access West Pharmaceutical Services (WST) conference presentations in November 2024?

Investors can access live audio webcasts through the 'Investors' section of West Pharmaceutical's website (westpharma.com). Replays will be available for approximately 90 days after each event.

When is West Pharmaceutical Services (WST) presenting at the UBS Global Healthcare Conference 2024?

West Pharmaceutical Services will present at the UBS Global Healthcare Conference in Rancho Pablos Verdes, California, on November 12, 2024, at 3:30 PM PST.

How long will West Pharmaceutical Services (WST) conference webcasts be available for replay?

The conference webcasts will be available for replay for approximately 90 days after each event on the company's website.